Literature DB >> 3017981

The functional domains of coagulation factor VIII:C.

R L Burke, C Pachl, M Quiroga, S Rosenberg, N Haigwood, O Nordfang, M Ezban.   

Abstract

A lack of factor VIII:C, manifested as a bleeding disorder due to the absence of clot formation, is known as hemophilia A, an X chromosome-linked inherited disease afflicting 1-2 males/10,000. To determine the minimum functional domain(s) essential for factor VIII:C activity, we have expressed the amino-terminal (92-kDa) and carboxyl-terminal (80-kDa) proteolytic cleavage products as individual, secreted polypeptides in monkey cells without the 909-residue central region. We have found that neither terminal domain alone is able to promote coagulation in factor VIII:C-deficient plasma. However, when the 92- and 80-kDa peptides are co-expressed, clotting activity is readily detected. Thus, these two chains alone constitute an active or activatable complex. The central domain is required neither for activity nor for the assembly of an active complex from two chains expressed in trans. These results suggest that a truncated derivative of factor VIII:C may be useful in coagulation therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017981

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

2.  Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.

Authors:  N Bihoreau; P Paolantonacci; C Bardelle; M P Fontaine-Aupart; S Krishnan; J Yon; J L Romet-Lemonne
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Tissue-specific expression in the salivary glands of transgenic mice.

Authors:  T R Mikkelsen; J Brandt; H J Larsen; B B Larsen; K Poulsen; J Ingerslev; N Din; J P Hjorth
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

4.  Localization of a factor VIII-inhibiting antibody epitope to a region between residues 338 and 362 of factor VIII heavy chain.

Authors:  J Ware; J R Toomey; D W Stafford
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein.

Authors:  M Burton; H Nakai; P Colosi; J Cunningham; R Mitchell; L Couto
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Factor VIII haplotypes frequencies in Tunisian hemophiliacs A.

Authors:  Hejer Elmahmoudi; Nejla Belhedi; Asma Jlizi; Kaouther Zahra; Balkis Meddeb; Amel Ben Ammar Elgaaied; Emna Gouider
Journal:  Diagn Pathol       Date:  2011-06-17       Impact factor: 2.644

7.  Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells.

Authors:  B S Chapman; R M Thayer; K A Vincent; N L Haigwood
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

8.  von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.

Authors:  I Rabinowitz; E A Tuley; D J Mancuso; A M Randi; B G Firkin; M A Howard; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

9.  Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A).

Authors:  B A McMullen; K Fujikawa; E W Davie; U Hedner; M Ezban
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

10.  Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A.

Authors:  E A Tuley; C Gaucher; S Jorieux; N K Worrall; J E Sadler; C Mazurier
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.